Physician profile
David S Baskin
NPI 1215962485
$14,573.54
in general payments reported to CMS, 2019-2025
15 companies · $6,606 in 2025
The $6,606 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $220 · 2021: $160 · 2022: $44.64 · 2023: $477 · 2024: $6,647 · 2025: $6,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6,000 · Travel and Lodging: $5,852 · Food and Beverage: $1,854 · Education: $23.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,000.00 |
| Travel and Lodging | $5,851.90 |
| Food and Beverage | $1,853.77 |
| Education | $23.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Theater. INC. | $6,968.95 | 2023-2025 | |
| Brainlab, INC. | $6,133.11 | 2019-2025 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Brainlab, INC., Image Guided Surgical Device |
| Medtronic, INC. | $485.89 | 2023-2025 | Strata, Stealthstation S8 Platform, Stealth Autoguide System |
| Pfizer INC. | $189.95 | 2019-2020 | |
| Zap Surgical Systems, INC. | $160.04 | 2021 | |
| Globus Medical, INC. | $147.36 | 2025 | Excelsius Gps |
| Medtronic USA, INC. | $135.19 | 2019 | |
| Medtronic Vascular, INC. | $108.56 | 2020 | |
| Karl Storz Endoscopy-America | $73.75 | 2023 | |
| Glaxosmithkline, LLC. | $57.22 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Stryker Corporation | $38.40 | 2023 | Adherus Autospray Dural Sealant |
| Omniscient Neurotechnology America LTD | $30.48 | 2023 | Quicktome |
| Novocure INC. | $27.31 | 2022 | |
| Sk Life Science, INC. | $17.33 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Baskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.